Polar molecular surface properties predict the intestinal absorption of drugs in humans

被引:636
作者
Palm, K
Stenberg, P
Luthman, K
Artursson, P
机构
[1] UNIV UPPSALA,DEPT ORGAN PHARMACEUT CHEM,S-75123 UPPSALA,SWEDEN
[2] UNIV UPPSALA,DEPT PHARMACEUT,S-75123 UPPSALA,SWEDEN
关键词
polar molecular surface area; hydrogen bonding potential; lipophilicity; drug absorption; intestinal drug transport; membrane permeability;
D O I
10.1023/A:1012188625088
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. A theoretical method has been devised for prediction of drug absorption after oral administration to humans. Methods. Twenty structurally diverse model drugs, ranging from 0.3 to 100% absorbed, were investigated. The compounds also displayed diversity in physicochemical properties such as lipophilicity, hydrogen bonding potential and molecular size. The dynamic molecular surface properties of the compounds were calculated, taking into account their three-dimensional shape and flexibility. Results. An excellent sigmoidal relationship was established between the absorbed fraction after oral administration to humans (FA) and the dynamic polar molecular surface area (PSA(d)) (r(2) = 0.94). The relationship was stronger than those obtained for more established predictors of drug absorption. Drugs that are completely absorbed (FA > 90%) had a PSA(d) less than or equal to 60 Angstrom(2) while drugs that are < 10% absorbed had a PSA(d) greater than or equal to 140 A(2). Conclusions. The results indicate that PSA(d) can be used to differentiate poorly absorbed drugs at an early stage of the drug discovery process.
引用
收藏
页码:568 / 571
页数:4
相关论文
共 34 条
  • [1] CORRELATION BETWEEN ORAL-DRUG ABSORPTION IN HUMANS AND APPARENT DRUG PERMEABILITY COEFFICIENTS IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
    ARTURSSON, P
    KARLSSON, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 175 (03) : 880 - 885
  • [2] Caco-2 monolayers in experimental and theoretical predictions of drug transport
    Artursson, P
    Palm, K
    Luthman, K
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) : 67 - 84
  • [3] BODEM G, 1972, CLIN PHARMACOL THER, V14, P26
  • [4] BODIN NO, 1974, ACTA PHARMACOL TOX, V35, P261
  • [5] ABSOLUTE BIOAVAILABILITY, RATE OF ABSORPTION, AND DOSE PROPORTIONALITY OF SULPIRIDE IN HUMANS
    BRESSOLLE, F
    BRES, J
    FAUREJEANTIS, A
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (01) : 26 - 32
  • [6] MOLECULAR FORCES GOVERNING NON-ELECTROLYTE PERMEATION THROUGH CELL MEMBRANES
    DIAMOND, JM
    WRIGHT, EM
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY SERIES B-BIOLOGICAL SCIENCES, 1969, 172 (1028): : 273 - +
  • [7] THE DISPOSITION AND METABOLISM OF C-14 OXPRENOLOL.HCL IN MAN
    DIETERLE, W
    FAIGLE, JW
    KUNG, W
    THEOBALD, W
    [J]. XENOBIOTICA, 1986, 16 (02) : 181 - 191
  • [8] ABSOLUTE ORAL BIOAVAILABILITY OF CIPROFLOXACIN
    DRUSANO, GL
    STANDIFORD, HC
    PLAISANCE, K
    FORREST, A
    LESLIE, J
    CALDWELL, J
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (03) : 444 - 446
  • [9] EICHELBAUM M, 1982, ARZNEIMITTEL-FORSCH, V32-1, P575
  • [10] Gajewski J. J., 1990, ADV MOL MODELLING, P65